乳腺癌的风险分析使用双边乳房扫描密度差异:一个案例对照研究
Zhang Zhang1, Xiaoyong Zhang2,3, Jiaqi Chen4
1Department of Intelligent Biomedical Systems Engineering Laboratory, Graduate School of Biomedical Engineering, Tohoku University.
The Tohoku journal of experimental medicine
|August 9, 2023
概括
一种新的测量方法,双边乳房扫描密度差异 (BMDD),量化了乳房不对称. 患有BMDD超过10%的女性患乳腺癌的风险增加了2.4倍,这表明BMDD是潜在的风险因素.
科学领域:
- 放射学和瘤成像学成像学
- 量化医学成像分析和分析.
- 乳腺癌风险评估 乳腺癌风险评估
背景情况:
- 放射科医生使用风险因素来评估乳腺癌风险.
- 已确定的定量风险因素包括年龄和乳房检查密度.
- 乳房非对称性在乳房扫描上可能表明早期阶段的质量.
研究的目的:
- 提出一个定量参数,双边乳房扫描密度差异 (BMDD),用于乳房不对称.
- 验证BMDD作为潜在的乳腺癌风险因素.
主要方法:
- 开发了一种半自动方法来估计乳腺图像密度.
- 计算的BMDD是乳房之间乳房密度的绝对差异.
- 进行了回顾性病例控制研究 (364例乳腺癌病例,364例对照,2006年7月至2014年10月).
主要成果:
- 在病例和对照组之间观察到BMDD的显著差异 (P < 0.001).
- 患有BMDD> 10%的女性患乳腺癌的风险增加了2.4倍 (OR,2.4;95% CI,1.3-4.5).
- 在不同年龄组和BI-RADS密度类别中,BMDD与乳腺癌风险有积极的关联.
结论:
- 双边乳房扫描密度差异 (BMDD) 有效量化了乳房不对称.
- BMDD是乳腺癌的一个潜在的独立风险因素.
- 这种定量测量可以帮助放射科医生评估乳腺癌风险.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
223
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
223
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
Hazard Ratio
158
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
158
The Mantel-Cox Log-Rank Test
428
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
428
Statistical Methods for Analyzing Epidemiological Data
411
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
411


